Anti-tuberculosis programs in Thailand: a cost analysis.
The standard regimen, a combination of isoniazid and thiacetazone, which has been used for treatment of tuberculosis (TB) in Thailand for the past 20 years is inexpensive, but possesses a high degree of toxicity and requires 18-24 months of continuous treatment, resulting in poor compliance and a low success rate of treatment.
The more efficacious short-course chemotherapy introduced into the National Tuberculosis Program in 1985 is limited by the high costs of drugs.
However, the cost of providing care is not limited only to drug costs but also includes other services costs.
Mots-clés Pascal : Tuberculose, Mycobactériose, Bactériose, Infection, Economie santé, Programme sanitaire, Traitement, Homme, Chimiothérapie, Analyse coût
Mots-clés Pascal anglais : Tuberculosis, Mycobacterial infection, Bacteriosis, Infection, Health economy, Sanitary program, Treatment, Human, Chemotherapy, Cost analysis
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0023911
Code Inist : 002B30A. Création : 199406.